Related references
Note: Only part of the references are listed.mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
Simon C. Johnson et al.
KIDNEY INTERNATIONAL (2019)
Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
Gabriele Civiletto et al.
EMBO MOLECULAR MEDICINE (2018)
Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
Stephanie E. Siegmund et al.
HUMAN MOLECULAR GENETICS (2017)
mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
Anna Jeong et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Ndufs4 related Leigh syndrome: A case report and review of the literature
Juan Dario Ortigoza-Escobar et al.
MITOCHONDRION (2016)
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond
Dudley W. Lamming
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration
Xinde Zheng et al.
ELIFE (2016)
Molecular mechanisms underlying genotype-dependent responses to dietary restriction
Jennifer Schleit et al.
AGING CELL (2013)
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Simon C. Johnson et al.
SCIENCE (2013)
Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition
Robert W. Gilkerson et al.
HUMAN MOLECULAR GENETICS (2012)
Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype
P. Kaufmann et al.
NEUROLOGY (2011)
THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY
Dianne J. Russell et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
Petra Kaufmann et al.
ARCHIVES OF NEUROLOGY (2009)
Presentation and diagnosis of mitochondrial disorders in children
Mary Kay Koenig
PEDIATRIC NEUROLOGY (2008)
Share Paper
